Work

Results of a Phase I Study with Mb-IL21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Refractory Acute Myeloid Leukemia

Year: 2021

Type: article

Source: Transplantation and Cellular Therapy

DOI: 10.1016/s2666-6367(21)00106-8

Authors: Stefan O. Ciurea, Jolie Schafer, Piyanuch Kongtim, Julianne Chen, Doris Soebbing, Kai Cao, Samer Srour, Elizabeth J Shpall, Marina Konopleva, Dean Anthony Lee, Richard Champlin

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650

OpenAlex ID: W3129142148

FWCI: 0.093

Cites:

Cited by: 1

Related to: 10